1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Characterization of the Pharmacodynamic Interaction between Parent Drug and Active Metabolite In Viv

Characterization of the Pharmacodynamic Interaction between Parent Drug and Active Metabolite In Viv

  1. Jatelka
    B. Tuk, M. F. van Oostenbruggen, V. M. M. Herben, J. W. Mandema, and M. Danhof

    J. Pharmacol. Exp. Ther. 1999 289: 1067-1074

    The pharmacodynamic interaction between midazolam and its active metabolite http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam was investigated to evaluate whether estimates of relevant pharmacodynamic parameters are possible after administration of a mixture of the two. Rats were administered 10 mg/kg of midazolam, 15 mg/kg of http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam, or a combination of 3.6 mg/kg of midazolam and 35 mg/kg of http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam. Increase in the 11.5- to 30-Hz frequency band of the electroencephalogram was used as the pharmacodynamic endpoint. The pharmacodynamics of midazolam and http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam after combined administration were first analyzed according to an empirical and a competitive interaction model to evaluate each model's capability in retrieving the pharmacodynamic estimates of both compounds. Both models failed to accurately estimate the true pharmacodynamic estimates of midazolam and http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam. The pharmacodynamic interaction was subsequently analyzed according to a new mechanism-based model. This approach is based on classical receptor theory and allows estimation of the in vivo estimated receptor affinity and intrinsic in vivo drug efficacy. The relationship between stimulus and effect is characterized by a monotonically increasing function f, which is assumed to be identical for midazolam and http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam. The pharmacodynamic interaction is characterized by the classical equation for the competition between two substrates for a common receptor site. This mechanism-based interaction model was able to estimate the pharmacodynamic parameters of both midazolam and http://jpet.aspetjournals.org/math/12pt/normal/alpha.gif-OH-midazolam with high accuracy. It is concluded that pharmacodynamic parameters of single drugs can be estimated after a combined administration when a mechanistically valid interaction model is applied.

    Discussion Thread